Altria and Marlboro are diversifying products due to declining smoking rates, with the flagship Marlboro brand generating most revenue.
3 reports, 1 independent
Updated Aug 30
Gone quiet
- Reports
- 3
- Developments
- 6
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Altria and Marlboro are diversifying products due to declining smoking rates, with the flagship Marlboro brand generating most revenue.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Altria's CEO Gifford and Gaurav Jain discussed Altria's profitability and questioned the company's discount brand strategy.Sub-event
- Altria and Marlboro are diversifying products due to declining smoking rates, with the flagship Marlboro brand generating most revenue.Sub-event
- FDA granted Juul marketing approval for e-cigarettes, raising competitive pressure on Altria's nicotine alternatives portfolio.Sub-event
- Altria, Marlboro, and Philip Morris are dealing with market pressures, including revenue impacts from Indonesia.Sub-event
Declining smoking rates prompt Altria/Marlboro to diversify products.1 source
- Altria invested $12.8 billion in Juul as part of its diversification strategy.
Keep exploring
The entities involved
Related events
Coverage
Newest first; wire copies grouped- Motley FoolThe 5 Best Dividend Stocks to Buy Now Coca-Cola and Altria are dependable consumer staples stocks. IBM and Cisco are blue chip tech giants with stable earnings growth. Realty Income is a leading REIT
- Motley FoolWant Another $500 in Annual Dividend Income? Invest $6,900 in These 3 High-Yield Stocks. Altria Group's cigarette sales are in decline, but smokeless options are picking up the slack. Healthpeak Prop
- Unknown outlet